The pharmaceutical sector has undergone many recent changes and a number of
studies involving the assessment of national pharmaceutical supplies in Sudan
were conducted in the past. Most of these studies used part of the core
indications for assessment of pharmaceutical supplies but none have used the whole package of indicators. Therefore it was essential to assess the pharmaceutical sector in Sudan in accordance with the national drug policy. The objectives of the study were to assess the country
medicine sector and its ability to implement the national drug policies;
identify the percentage of the public who are able to access essential
medicines; and whether the medicines received are of accepted quality and
rationally used. Fifteen key medicines that are the mostly commonly used in the
northern states were selected as a basket of medicines for this study. This study used the World Health Organizations package for pharmaceutical sector assessment, level II outcome indicators for health facilities survey. The survey was conducted in six states that make up the
geographical area of northern Sudan; namely Khartoum state, Nile River state,
Red Sea state, North Kordofan state and Kassala state, in addition to Southern Darfur to represent the conflict area.
The health facilities chosen included both the public and private health sectors and medicine warehouses. Regarding patients included in the surveyed sample, they were selected using retrospective and prospective sampling. The data analyzed to identify the gaps in the policies already in
place and to identify any interventions needed to correct any deficits encountered.
The Southern states were excluded due to accessibility reasons and due to lack
of any clear structural health system. Therefore, results of this study were not including the southern states.